We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor in Cancer Patients

News   Dec 14, 2009

 
Array BioPharma Announces Positive Interim Results for Phase 1 Study of Its HER2 Inhibitor in Cancer Patients
 
 
 

RELATED ARTICLES

Blood Test Could Identify Women at Risk for Gestational Diabetes

News

Early screening could allow for lifestyle changes before gestational diabetes develops.

READ MORE

Possible Reason Why Some People with Brain Markers of Alzheimer’s Don't Have Dementia

News

Why do some people with amyloid plaques and tau tangles typical of symptomatic Alzheimer’s disease, not have dementia?

READ MORE

Zika Vaccine Clinical Trial Begins

News

Vaccinations have begun in a first-in-human trial of an experimental live, attenuated Zika virus vaccine.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE